A Phase 2 Randomized Study of Tarceva (Erlotinib) as a S

  • Dudek, Arkadiusz Z (PI)

Project: Research project

Project Details

Description

A Phase 2 Randomized Study of Tarceva (Erlotinib) as a Single Agent or Intercalated with Combination Chemotherapy in Patients with Newly Diagnosed Advanced Non-small Cell
StatusFinished
Effective start/end date3/1/072/28/11

Funding

  • OSI Pharmaceuticals, Inc.